The blocking of PD-L1 by using the antibody reduced (10–20%) the growth of three cell lines with higher PD-L1 expressions (JHH-6, Huh7, and HLF) compared to the control alone (HCC cells + Jurkat, p < 0.05). Here, CD274 is linked to hepatocellular carcinoma.